GSK plc
Search results
We are Haleon. We are a world-leading consumer health company with a clear purpose to deliver better everyday health with humanity. Our leading brands are built on science, innovation and human understanding and are trusted by millions of consumers globally.
- Who We Are
The power of brands. We have nine large-scale multinational...
- Strategy
Using our competitive strengths of deep human understanding...
- Governance
Haleon is listed on the New York Stock Exchange (NYSE), and...
- Where we operate
Nos marques appartiennent ou sont concédée(s) au groupe...
- Who We Are
Feb 22, 2022 · Haleon is the name of the new company that will result from the proposed demerger of GSK's Consumer Healthcare business in mid-2022. Haleon will have a portfolio of global brands, including Sensodyne, Voltaren, Panadol and Centrum, and will be listed on the London Stock Exchange.
Request samples. At Haleon, formerly GSK Consumer Healthcare, we are dedicated to delivering better everyday health with humanity, and we know how hard you work towards the same goal while providing expert care and guidance to your patients, day in and day out.
- GSK Share Consolidation
- Disclaimer
- Expected Timetable of Principal Events
- GeneratedCaptionsTabForHeroSec
At the GSK General Meeting on 6 July 2022, alongside the demerger, GSK shareholders also approved the consolidation of GSK shares (the “GSK Share Consolidation”). The GSK Share Consolidation is expected to take place after the market closes today. It is expected that admission and dealings in the new GSK shares on the LSE will commence at 8.00 a.m....
GSK makes no representation or warranty as to the appropriateness, accuracy, completeness or reliability of the information in this announcement. This announcement is for information purposes only and is not intended to and does not constitute or form part of any offer or invitation to purchase, otherwise acquire, subscribe for, sell, otherwise dis...
The times and dates set out in the timetable below and throughout this announcement are indicative only and based on GSK’s current expectations and may be subject to change without further notice.
Haleon plc, the new consumer healthcare company, has been listed on the London Stock Exchange and the New York Stock Exchange. GSK shareholders have also approved the consolidation of GSK shares, which will take effect after the market closes on 18 July 2022.
Jun 1, 2022 · On 18 July 2022, GSK plc demerged 80% of its Consumer Healthcare business to GSK shareholders, creating Haleon plc as an independent listed company. GSK also consolidated its share capital and provided information on the Demerger, the GSK Share Consolidation and the tax implications.
Jul 18, 2022 · Haleon plc (“Haleon”) is pleased to announce the completion of the demerger of the Consumer Healthcare business from the GSK Group to form the Haleon Group.
Jul 18, 2022 · Haleon launches as an independent consumer health company, completing its GSK demerger. Trading commenced on the LSE with the CEO leading the ceremony. NYSE trading and a market-opening event are set for July 20, 2022.
People also ask
What happened to GSK & haleon?
Why did GSK create haleon?
When did haleon & GSK merge?
Is haleon a good investment for GSK shareholders?
